Changing patterns and trends in systemic fungal infections.
about
A comparative histopathological study of systemic candidiasis in association with experimentally induced breast cancerC-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungiBioprospecting Sponge-Associated Microbes for Antimicrobial CompoundsClinical Appearance of Oral Candida Infection and Therapeutic StrategiesCopper at the Fungal Pathogen-Host AxisGastrointestinal Basidiobolomycosis, a Rare and Under-diagnosed Fungal Infection in Immunocompetent Hosts: A Review ArticleLiposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1Comparative lipidomics in clinical isolates of Candida albicans reveal crosstalk between mitochondria, cell wall integrity and azole resistanceIdentification and characterization of antifungal compounds using a Saccharomyces cerevisiae reporter bioassayProteomic analysis of Rta2p-dependent raft-association of detergent-resistant membranes in Candida albicansEfficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens.Agent-based modeling approach of immune defense against spores of opportunistic human pathogenic fungi.Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherenceForest soil metagenome gene cluster involved in antifungal activity expression in Escherichia coli.Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.An Antifungal Mechanism of Protolichesterinic Acid from the Lichen Usnea albopunctata Lies in the Accumulation of Intracellular ROS and Mitochondria-Mediated Cell Death Due to Apoptosis in Candida tropicalisMolecular analysis of fungal populations in patients with oral candidiasis using internal transcribed spacer region.Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients.Comparative lipidomics of azole sensitive and resistant clinical isolates of Candida albicans reveals unexpected diversity in molecular lipid imprints.A Nonredundant Phosphopantetheinyl Transferase, PptA, Is a Novel Antifungal Target That Directs Secondary Metabolite, Siderophore, and Lysine Biosynthesis in Aspergillus fumigatus and Is Critical for Pathogenicity.Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands.Proteomic analysis of human umbilical vein endothelial cells incubated with Cryptococcus neoformans var. neoformans.Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).Susceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey.Resistance to antifungals that target CYP51.The Aspergillus fumigatus dihydroxyacid dehydratase Ilv3A/IlvC is required for full virulence.Identification of 3-phenylaminoquinolinium and 3-phenylaminopyridinium salts as new agents against opportunistic fungal pathogens.Approaching the functional annotation of fungal virulence factors using cross-species genetic interaction profiling.The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme.Aspergillus fumigatus and related species.A glucose sensor in Candida albicansThe mycobiota: interactions between commensal fungi and the host immune system.A virtual infection model quantifies innate effector mechanisms and Candida albicans immune escape in human blood.Sequence resources at the Candida Genome DatabaseN-Cyclo-propyl-N-[2-(2,4-difluoro-phen-yl)-2-hy-droxy-1-(1H-1,2,4-triazol-1-yl)prop-yl]-2-(5-methyl-2,4-dioxo-1,2,3,4-tetra-hydro-pyrimidin-1-yl)acetamide dichloro-methane 0.62-solvate.The Prevalence of fungal infections in children with hematologic malignancy in Ali-Asghar Children Hospital between 2005 and 2010.Protein phosphatase Pph3 and its regulatory subunit Psy2 regulate Rad53 dephosphorylation and cell morphogenesis during recovery from DNA damage in Candida albicans.
P2860
Q24605538-70E9D980-B7D1-4666-996E-981CE619E5EEQ24629672-440CA650-B9E0-412D-B4F4-52F121FCA9AFQ26752805-2C809A3A-FED8-4F82-8268-69DEE8135F3AQ26770698-C5018565-31FB-4A07-B63B-450B9BDF12DBQ27010264-D5C42F1A-5F0F-487E-B1F9-180FEE0217FDQ28083124-36D4EE9D-678E-4255-AEF3-4AC08FF65DC3Q28298468-CA0A059C-675B-4382-B8F0-23FC1BB41723Q28471781-4050AE27-5205-425C-9D2E-E8E8AABCC03AQ28480747-B1039097-BA73-40C5-9397-59B00717CBACQ28483330-FC650280-251B-4E78-AA44-D867C6EDE15DQ28483932-53A8713A-950F-48D1-AC71-76155D96E9AAQ30240770-6E9AB3D0-5725-4CDE-A5CC-884AF6865FF6Q30318077-54883EA6-1E0E-48DC-A651-DAA44195EFF9Q30513831-4A020F2E-00EC-4018-A882-49211C236665Q30862390-A1295C7E-B933-439D-BEC0-D777B98F81ACQ33309144-130913EE-0883-4276-9304-E747AD685217Q33490772-C3BF2E17-15FD-40F7-BAD1-8CEEA64C0D99Q33734709-11C87729-3C27-47A3-A303-4B39ECD1FD0AQ33825810-54C51762-9112-45CC-A772-87B36CB6EA0AQ33860940-2DA87C29-4426-46E9-AD0C-3A53F0A97CC7Q33894971-D4428E94-5470-47F7-9EDE-138AC5074DF0Q33916498-09F3F329-FE59-4B5B-B0FF-832164DA2F8DQ34013416-2F3D8FB5-DE83-4E12-B427-7D24D72F31E5Q34017001-07A3FE39-2371-4B4F-AD51-90E73BE1E21BQ34036214-D0D88BCC-8023-49A4-99EB-F37302562E7DQ34150915-F975E7D6-CC2E-4F2F-AB4D-7CBB785963ABQ34187936-99987A2A-E722-4C02-8C41-5CC7C621423CQ34276700-4CA2F341-F6BA-475C-A30D-8252C94C75E3Q34426797-4C90D356-D9ED-4307-837A-4D7B36A569FDQ34459120-D5772EE3-6950-422D-830E-2E32934F210BQ34539851-7105D597-5C50-43BC-AECA-8206933713FDQ34597385-15F9E7FF-0D63-4158-8764-26D25B5E1B5FQ35045054-EDB9F236-11A6-4BED-86D7-319DA97879F3Q35075215-E37C613F-E0D6-425F-A23E-A6DF52E21BDCQ35096262-1971AFE6-5D3B-421D-844E-32981D57FBB3Q35105573-97128721-31E4-4DD0-A769-EA268E73D61AQ35179231-89FCDC8D-82A4-4F09-8D0E-CF28D5326F77Q35437454-BB267144-7678-4585-B5AF-A2BE2A8404FBQ35470678-8006CE12-B053-4564-84A6-4BA647504CEEQ35530396-3C949E2F-4EA5-429C-90B3-1FC9BEC271E8
P2860
Changing patterns and trends in systemic fungal infections.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Changing patterns and trends in systemic fungal infections.
@ast
Changing patterns and trends in systemic fungal infections.
@en
type
label
Changing patterns and trends in systemic fungal infections.
@ast
Changing patterns and trends in systemic fungal infections.
@en
prefLabel
Changing patterns and trends in systemic fungal infections.
@ast
Changing patterns and trends in systemic fungal infections.
@en
P356
P1476
Changing patterns and trends in systemic fungal infections.
@en
P304
P356
10.1093/JAC/DKI218
P407
P478
56 Suppl 1
P577
2005-09-01T00:00:00Z